KIT Gene Leukemia acute myeloid Genetic Test
Components: KIT Gene Leukemia acute myeloid Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cancer
Doctor: Oncologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test gene KIT
Test Details:
The KIT gene is a gene that encodes for a protein called KIT receptor tyrosine kinase. This protein is involved in the regulation of cell growth and differentiation. Mutations in the KIT gene have been found to be associated with various types of cancer, including acute myeloid leukemia (AML).
Acute myeloid leukemia is a type of blood cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of specific genes. It allows for the identification of mutations or changes in the DNA sequence that may be associated with diseases like leukemia.
In the context of AML, NGS genetic testing of the KIT gene can help identify specific mutations that may be driving the development or progression of the disease. This information can be used to guide treatment decisions, as certain mutations may respond better to targeted therapies.
Overall, the KIT gene NGS genetic test in acute myeloid leukemia aims to provide personalized and targeted treatment options based on the specific genetic profile of the tumor.
| Test Name | KIT Gene Leukemia acute myeloid Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIT Gene Leukemia, acute myeloid NGS Genetic DNA Test gene KIT |
| Test Details |
The KIT gene is a gene that encodes for a protein called KIT receptor tyrosine kinase. This protein is involved in the regulation of cell growth and differentiation. Mutations in the KIT gene have been found to be associated with various types of cancer, including acute myeloid leukemia (AML). Acute myeloid leukemia is a type of blood cancer that affects the bone marrow and blood cells. It is characterized by the rapid growth of abnormal white blood cells, which interfere with the production of normal blood cells. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of specific genes. It allows for the identification of mutations or changes in the DNA sequence that may be associated with diseases like leukemia. In the context of AML, NGS genetic testing of the KIT gene can help identify specific mutations that may be driving the development or progression of the disease. This information can be used to guide treatment decisions, as certain mutations may respond better to targeted therapies. Overall, the KIT gene NGS genetic test in acute myeloid leukemia aims to provide personalized and targeted treatment options based on the specific genetic profile of the tumor. |
